Donate

Global Stories

Advocates in Canada Fight for Free Access for Insulin’s 100th Anniversary

Advocates in Canada Fight for Free Access for Insulin’s 100th Anniversary

Canada is the home of insulin. It was invented here and even features on our $100 bill. And yet, 100 years later, there is no Canada-wide coverage for insulin. Our Chapter's current campaign is called #freeinsulin100. Our goal is to ensure the passage of federal legislation implementing a national pharmacare program by the end of 2021, which would include all Provinces and Territories providing insulin free of charge for all people who require it by the end of 2021. Currently Canada stands alone as the only country in the world with a national public healthcare system that does not also cover required prescription medication.
Read more

Creativity and Activism: Another World is Possible

Creativity and Activism: Another World is Possible

Here are five reasons - showcasing #insuiln4all and other social change movements around the world - why joining art, creativity and activism together is so powerful. It fosters self-expression, community building, activation, it is inspiring and attention grabbing, and it leads activists to better engage with the media. Read more

There Is No Insulin in Iran

There Is No Insulin in Iran

Shortages of insulin are not something new in Iran, but recently there is no insulin at all. We were shocked by responses from our politicians who said, "The shortage is just for pens and we have plenty of internal production of insulin. People can replace it." However, the types of insulin that are produced in Iran are NPH and R. Few consumers in Iran use NPH. About 70 percent of Iranian people with diabetes use insulin pens. Read more

Representing Latin America’s Insulin Access Needs at the World Health Organization Workshop

Representing Latin America’s Insulin Access Needs at the World Health Organization Workshop

I felt empowered that the voices of those of us living with type 1 diabetes were respectfully listened and taken into account by the WHO. As noted: Patients have power. Being able to represent my country made those words feel real, and it had tremendous value for me. Read more

People with Type 1 Diabetes Take Action After the Explosion in Beirut

People with Type 1 Diabetes Take Action After the Explosion in Beirut

“My first thoughts when it happened was that an earthquake had hit, because the earth shook so hard that I could literally feel tectonic plates shifting. The first thing I did was grab my insulin supplies and run down the stairs.” Read more

Fighting for LGBTQ+ Justice and #insulin4all

Fighting for LGBTQ+ Justice and #insulin4all

Delaying care due to these fears as a queer or trans person is not uncommon in any medical setting, however if you delay care living with diabetes, it can lead to life-threatening complications or even worse. It’s imperative that LGBTQ+ people living with diabetes and other chronic illnesses have the security, affirmation and resources to access the care they need. Read more

An Insulin Resolution is Necessary for Lebanon and the World

An Insulin Resolution is Necessary for Lebanon and the World

Lebanon’s recent financial crisis has caused a dollar shortage that, since September, has restricted the ability of medical supply importers to import vital medical supplies. First it started with masks, gloves, and other protective gear, as well as ventilators and spare parts, and now even essential diabetes supplies are sometimes unavailable. Read more

My Black Diabetic Life Matters

My Black Diabetic Life Matters

When I left the hospital I remember wondering, “Why did my mom have to beg those people to do their job when I was visibly sick?” A few years later after I had dealt with numerous visits, checkups, and insurance calls, I became aware of the medical side of racism. Read more

How Shareholders Benefit from Insulin Price Increases

How Shareholders Benefit from Insulin Price Increases

In March of this year, researchers at the University of Pittsburgh provided evidence that the net price of insulin medicines in the United States had also soared – by 51% between 2008-2017. This indicates that while other intermediaries had benefited from list price increases, the manufacturers had too. This may seem obvious, but having data to prove it is important. Read more

Global Type 1 Diabetes Coronavirus Perspectives

Global Type 1 Diabetes Coronavirus Perspectives

Ten people living with type 1 diabetes share their perspectives about the impact of the coronavirus on their country and their health. Read more